Healthcare Sales & Marketing Network News: antifungal

Searching News Database: antifungal

HSMN NewsFeed - 29 Oct 2024
Protega Pharmaceuticals Receives FDA Approval for ROXYBOND(TM) (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Mar 2024
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA(R) (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Dec 2020
New Dermatology Company Resilia Pharmaceuticals Begins Operations
Biopharmaceuticals Dermatology

HSMN NewsFeed - 14 Aug 2020
Lupin Presents Phase 3 Data for Solosec(R) (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2020
F2G's Olorofim Receives Both FDA Orphan Drug Designation for Coccidioidomycosis (Valley Fever) and FDA QIDP Designation for Multiple Fungal Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Jun 2020
Amplyx Pharmaceuticals Expands Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Oct 2019
Eyevance Pharmaceuticals Acquires TOBRADEX(R) ST and NATACYN(R)
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 14 Jun 2019
SCYNEXIS Appoints Dr. Nkechi Azie as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2019
F2G Appoints Dr. Patrick Vink as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2019
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 29 May 2018
UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 1 May 2018
SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention of Recurrent VVC
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Mar 2018
Amplyx Pharmaceuticals Receives Fourth "Qualified Infectious Disease Product" (QIDP) Designation from the FDA for APX001
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2017
Amgen Launches The ENBREL Mini(TM) Single-Dose Prefilled Cartridge With AutoTouch(TM) Reusable Autoinjector That Is Ergonomically Designed For Patients
Biopharmaceuticals Devices Drug Delivery Product Launch

HSMN NewsFeed - 2 Aug 2017
Amplyx Pharmaceuticals Raises $67 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 May 2016
Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2016
Pfizer to Acquire Anacor
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 12 Nov 2015
Viamet Appoints Dr. Volker Herrmann as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Nov 2015
Amplyx Pharmaceuticals Secures $40.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Sep 2015
Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., as Senior Vice President and Chief Technology Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Feb 2015
Cidara Therapeutics Completes $42 Million Private Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Feb 2015
Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2014
Viamet Announces $60 Million Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Sep 2014
NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jul 2014
Anacor Pharmaceuticals and Sandoz Enter Into an Agreement for the Commercialization of KERYDIN in the United States
Biopharmaceuticals Dermatology Distribution

HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Feb 2014
SCYNEXIS Appoints Carole Sable, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2013
CorMedix Announces First Sales of Neutrolin(R) in the European Union
Biopharmaceuticals Product Launch

HSMN NewsFeed - 12 Dec 2013
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Nov 2013
Merck’s New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL(R) (posaconazole) Receives FDA Priority Review
Biopharmaceuticals FDA Regulatory

HSMN NewsFeed - 15 Nov 2013
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu(R) Cream, 1%
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Oct 2013
Devon Medical Announces Global Availability of Foot Dressing for Negative Pressure Wound Therapy (NPWT)
Devices Wound Care Product Launch

HSMN NewsFeed - 3 Oct 2013
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 30 Sep 2013
Cimzia(R) (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Sep 2013
Osmotica Pharmaceutical Corp. Announces the Appointment of Gene Wright, Pharm.D., Ph.D. as Vice President, Head of Global Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Feb 2013
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Feb 2013
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory

HSMN NewsFeed - 4 Sep 2012
HemCon(R) GuardIVa(R) Antimicrobial Hemostatic IV Dressing Obtains Additional FDA Clearance and HCPCS Reimbursement Codes
Devices FDA Reimbursement

HSMN NewsFeed - 13 Apr 2012
Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology

HSMN NewsFeed - 16 Dec 2011
Valeant Announces Successful Results From Phase III Onychomycosis Trials
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2011
TOPICA Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA

HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals

HSMN NewsFeed - 3 May 2011
Optimer Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2011
Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 Apr 2011
Anacor Pharmaceuticals Appoints William J. Rieflin to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Oct 2010
PinPointe FootLaser Receives FDA Clearance for the Treatment of Nail Fungus (Onychomycosis)
Devices FDA

HSMN NewsFeed - 5 Oct 2010
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 3 May 2010
Basilea's Toctino(R) receives marketing authorization in Italy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Mar 2010
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Candida Bloodstream Pathogens
Diagnostics FDA

HSMN NewsFeed - 18 Feb 2010
TOPICA Names Mark W. Davis Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2009
FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2009
Basilea's Toctino(R) receives marketing authorization in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 14 Oct 2009
Basilea's Toctino(R) receives marketing authorization in Switzerland
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 7 Sep 2009
REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder
Biopharmaceuticals Urology

HSMN NewsFeed - 1 Jun 2009
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 13 May 2009
UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2009
Basilea's Toctino(R) receives marketing authorization in Spain
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 29 Apr 2009
Basilea's Toctino(R) Receives Marketing Authorization in Netherlands
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 17 Mar 2009
Basilea's Toctino(R) receives marketing authorization in Austria
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 11 Mar 2009
Basilea's Toctino(R) Receives Marketing Authorization in Belgium and Luxemburg
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 24 Feb 2009
Basilea Pharmaceutica files claims against Johnson&Johnson over its handling of ceftobiprole (ZEFTERA(TM)/Zevtera(TM)) clinical studies
Biopharmaceuticals Litigation

HSMN NewsFeed - 7 Jan 2009
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
Devices FDA

HSMN NewsFeed - 6 Jan 2009
Anacor Raises $50 Million in Equity Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Dec 2008
Basilea Pharmaceutica opens U.S. phase III study on alitretinoin for the treatment of severe chronic hand eczema
Biopharmaceuticals Dermatology

HSMN NewsFeed - 21 Nov 2008
Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad-spectrum antibiotic, receives a positive opinion from the CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in France
Biopharmaceuticals Regulatory Dermatology

HSMN NewsFeed - 15 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 22 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Denmark
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 12 Sep 2008
Is Rx-to-OTC Move the Right Prescription to Protect Pharma Revenues & Cut Healthcare Costs?
Biopharmaceuticals

HSMN NewsFeed - 8 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 28 Jul 2008
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 28 Jul 2008
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2008
Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Jun 2008
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Jun 2008
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 29 May 2008
Medline's Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008
Devices Wound Care

HSMN NewsFeed - 22 May 2008
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
Biopharmaceuticals Dermatology

HSMN NewsFeed - 19 May 2008
Premier Hospitals, Healthcare Providers to Save with New Pricing on Two Pfizer Branded Antifungal Products
Biopharmaceuticals Group Purchasing

HSMN NewsFeed - 16 May 2008
Nomir Medical Initiates Pivotal Trial of its Noveon(R) Dual Wave Length Device for the Treatment of Onychomycosis
Devices

HSMN NewsFeed - 17 Apr 2008
Arpida Provides Comprehensive Overview of Pivotal Phase III Trial Data
Biopharmaceuticals

HSMN NewsFeed - 7 Apr 2008
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 31 Mar 2008
BioAlliance Pharma Expands Its Loramyc(TM) Franchise by Signing a South East Asia Deal Worth up to $12 Million with the Leading Korean Pharma Company Handok
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals

HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 26 Feb 2008
Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 21 Feb 2008
Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Jan 2008
Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
Biopharmaceuticals HIV/AIDS Regulatory

HSMN NewsFeed - 23 Jan 2008
FDA Approves Additional Indication for Astellas' MYCAMINE(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Jan 2008
Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Nycomed Signs Definitive Agreement to Acquire Bradley Pharmaceuticals, Inc., Strengthening US Specialty Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2007
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Oct 2007
Accentia Biopharmaceuticals Announces Completion of Enrollment in Fast-Tracked Pivotal Phase 3 Clinical Trial of SinuNase for Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 8 Oct 2007
GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2007
Interim Results from a New Trial of CANCIDAS(R) (caspofungin acetate) in Pediatric Patients with Documented Fungal Infections
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2007
Barrier Therapeutics Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Hyphanox(TM) for Onychomycosis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 18 Sep 2007
New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Study Presented on Use of CANCIDAS(R) (caspofungin acetate) as Empirical Therapy of Suspected Invasive Fungal Infections in Pediatric Patients with Persistent Fever and Neutropenia
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2007
Canadian Regulatory Authority has Accepted for Review New Drug Submission for Ceftobiprole
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Sep 2007
Basilea Announces the Submissions of Marketing Authorization Applications in the EU for Alitretinoin, an Investigational Drug for the Treatment of Severe Refractory Chronic Hand Eczema
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 2 Aug 2007
Barrier Therapeutics Introduces New Xolegel Duo(TM) Offering at the American Academy of Dermatology (AAD) Summer Academy Meeting 2007
Biopharmaceuticals Dermatology

HSMN NewsFeed - 20 Jul 2007
Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 17 Jul 2007
Basilea Announces Filing of New Drug Submission in Canada for Ceftobiprole
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2007
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jul 2007
Par Pharmaceutical Licenses U.S. Commercialization Rights to Loramyc(TM) From BioAlliance Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Jun 2007
Serenex Secures $31 Million in Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Jun 2007
MicuRx Pharmaceuticals Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jun 2007
Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 May 2007
Swiss Regulatory Authority Grants Accelerated Assessment of Planned Market Authorization Application for Ceftobiprole
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 May 2007
Efficacy and Safety Profile of Basilea's Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
Biopharmaceuticals Dermatology

HSMN NewsFeed - 16 May 2007
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 14 May 2007
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 7 May 2007
CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
Biopharmaceuticals Dermatology

HSMN NewsFeed - 2 May 2007
CollaGenex Pharmaceuticals Provides Update on 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
Biopharmaceuticals Dermatology

HSMN NewsFeed - 30 Apr 2007
NCCN Updates Prevention and Treatment of Cancer-Related Infections Guidelines
Oncology

HSMN NewsFeed - 30 Apr 2007
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
Biopharmaceuticals Dermatology

HSMN NewsFeed - 23 Apr 2007
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
Biopharmaceuticals Dermatology

HSMN NewsFeed - 19 Apr 2007
Xechem Receives $7 Million from New Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Mar 2007
Barrier Therapeutics Announces Azoline (Pramiconazole) Dose Ranging Study in Tinea Versicolor Meets Primary and Secondary Endpoints
Biopharmaceuticals Dermatology

HSMN NewsFeed - 20 Mar 2007
New Cancer Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Mar 2007
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
Biopharmaceuticals Regulatory Dermatology

HSMN NewsFeed - 6 Mar 2007
Barrier Therapeutics Announces Agreement to Co-Promote Vusion(TM) Ointment to Pediatricians in the United States
Biopharmaceuticals Dermatology

HSMN NewsFeed - 28 Feb 2007
Schering-Plough Announces Executive Changes in Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2007
Hana Biosciences Appoints Lyn Wiesinger to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Feb 2007
Basilea Reports Positive Phase III Results for Alitretinoin
Biopharmaceuticals

HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Feb 2007
Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel(R) (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
Biopharmaceuticals Dermatology

HSMN NewsFeed - 25 Jan 2007
The New England Journal Of Medicine Publishes Two Landmark Studies Of NOXAFIL(R) (Posaconazole) in the Prevention of Invasive Fungal Infections
Biopharmaceuticals

HSMN NewsFeed - 12 Jan 2007
Pipex Pharmaceuticals Acquires Minority Interest in Its Effective Pharmaceuticals Subsidiary
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Jan 2007
Astellas Pharma US, Inc. Announces Availability of MYCAMINE(R) 100mg Vial
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2007
Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial
Biopharmaceuticals

HSMN NewsFeed - 26 Dec 2006
Astellas Pharma US, Inc. Submits Supplemental New Drug Application For Antifungal Product MYCAMINE(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Dec 2006
CollaGenex Pharmaceuticals Signs License and Supply Agreement with MediGene for Marketing Rights to Oracea in EU and Certain Other Countries
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 19 Dec 2006
Basilea Announces Start of Phase III Program for Isavuconazole, Its Third Investigational Drug to Reach Pivotal Trials
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
Basilea to Co-Promote Ceftobiprole
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2006
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
Biopharmaceuticals Licensing

HSMN NewsFeed - 17 Nov 2006
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 Nov 2006
Noxafil(R) (Posaconazole) Oral Suspension Approved in European Union for Prevention of Invasive Fungal Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Nov 2006
Pipex Therapeutics Merges With Sheffield Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Oct 2006
Pfizer Assists World Health Organization in Search for New Treatments Against Diseases of the Developing World
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2006
Schering-Plough Announces FDA Approval of NOXAFIL(R) (Posaconazole) for Treatment of Oropharyngeal Candidiasis (OPC)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Oct 2006
Immtech Pharmaceuticals Announces Antimicrobial Pipeline Progress
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
Basilea Reports Excellent Pivotal Data for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Investigational Antibiotic, at ICAAC
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
New Data Confirming Broad Spectrum of Basilea's Late-Stage Antifungal, BAL8557, Presented at the ICAAC Conference
Biopharmaceuticals

HSMN NewsFeed - 22 Sep 2006
European Union's CHMP Adopts Positive Opinion for NOXAFIL(R) (posaconazole) Oral Suspension for Prevention of Invasive Fungal Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Sep 2006
Anacor Expands Clinical Development Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2006
Schering-Plough Announces FDA Approval of NOXAFIL(R) (Posaconazole) for Prevention of Invasive Fungal Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jul 2006
Ranbaxy's Joint Venture in Japan Launches Generic Clarithromycin & Terbinafine Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 30 May 2006
CollaGenex Pharmaceuticals Receives FDA Approval for Oracea(TM)
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 22 May 2006
FDA Grants Fast Track Designation to Nektar's Amphotericin B Inhalation Powder (ABIP) for Prevention of Pulmonary Fungal Infections in At-Risk Patients
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 145

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 145 additional stories matching:
antifungal
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.